BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25012956)

  • 1. A RAD52 genetic variant located in a miRNA binding site is associated with glioma risk in Han Chinese.
    Lu C; Chen YD; Han S; Wei J; Ge Y; Pan W; Jiang T; Qiu XG; Yang M
    J Neurooncol; 2014 Oct; 120(1):11-7. PubMed ID: 25012956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a functional RAD52 genetic variant locating in a miRNA binding site with risk of HBV-related hepatocellular carcinoma.
    Li Z; Guo Y; Zhou L; Ge Y; Wei L; Li L; Zhou C; Wei J; Yuan Q; Li J; Yang M
    Mol Carcinog; 2015 Sep; 54(9):853-8. PubMed ID: 24729511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAD52 gene polymorphisms are associated with risk of colorectal cancer in a Chinese Han population.
    Zhang L; Zhang Y; Tang CH; Su CM
    Medicine (Baltimore); 2017 Dec; 96(49):e8994. PubMed ID: 29245274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an SCLC susceptibility rs7963551 genetic polymorphism in a previously GWAS-identified 12p13.33 RAD52 lung cancer risk locus in the Chinese population.
    Han S; Gao F; Yang W; Ren Y; Liang X; Xiong X; Pan W; Zhou L; Zhou C; Ma F; Yang M
    Int J Clin Exp Med; 2015; 8(9):16528-35. PubMed ID: 26629180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
    Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
    Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibility.
    Jiang Y; Qin Z; Hu Z; Guan X; Wang Y; He Y; Xue J; Liu X; Chen J; Dai J; Jin G; Ma H; Wang S; Shen H
    Carcinogenesis; 2013 Mar; 34(3):689-93. PubMed ID: 23188672
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li M; Chen R; Ji B; Fan C; Wang G; Yue C; Jin G
    Ther Adv Respir Dis; 2020; 14():1753466620918192. PubMed ID: 32401173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-binding site functional polymorphisms in DNA repair genes RAD51, RAD52, and XRCC2 and breast cancer risk in Chinese population.
    Cao J; Luo C; Peng R; Guo Q; Wang K; Wang P; Ye H; Song C
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27726100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-strand break repair and colorectal cancer: gene variants within 3' UTRs and microRNAs binding as modulators of cancer risk and clinical outcome.
    Naccarati A; Rosa F; Vymetalkova V; Barone E; Jiraskova K; Di Gaetano C; Novotny J; Levy M; Vodickova L; Gemignani F; Buchler T; Landi S; Vodicka P; Pardini B
    Oncotarget; 2016 Apr; 7(17):23156-69. PubMed ID: 26735576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations in the homologous recombination repair pathway genes modify risk of glioma.
    Zhang H; Liu Y; Zhou K; Zhou C; Zhou R; Cheng C; Wei Q; Lu D; Zhou L
    J Neurooncol; 2016 Jan; 126(1):11-17. PubMed ID: 26514363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAD52 variants predict platinum resistance and prognosis of cervical cancer.
    Shi TY; Yang G; Tu XY; Yang JM; Qian J; Wu XH; Zhou XY; Cheng X; Wei Q
    PLoS One; 2012; 7(11):e50461. PubMed ID: 23209746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
    Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
    Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum complementation group f polymorphisms influence risk of glioma.
    Cheng HB; Xie C; Zhang RY; Hu SS; Wang Z; Yue W
    Asian Pac J Cancer Prev; 2013; 14(7):4083-7. PubMed ID: 23991957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
    Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
    Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic variation in DNA repair gene RAD52 is associated with the response to platinum-based chemotherapy in SCLC patients].
    Li HM; Yuan P; Yu DK; Ma F; Tan WW; Feng T; Yang J; Huang Y; Lin DX; Xu BH; Tan W
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):504-9. PubMed ID: 27531263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
    Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
    Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Variants of VEGF (rs201963 and rs3025039) and KDR (rs7667298, rs2305948, and rs1870377) Are Associated with Glioma Risk in a Han Chinese Population: a Case-Control Study.
    Zhang J; Yang J; Chen Y; Mao Q; Li S; Xiong W; Lin Y; Chen J; Ge J
    Mol Neurobiol; 2016 May; 53(4):2610-8. PubMed ID: 26093379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in XRCC1 gene and susceptibility to glioma in Chinese Han population.
    Jin Z; Xu H; Zhang X; Zhao G
    Tumour Biol; 2014 Jan; 35(1):357-62. PubMed ID: 23918303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.
    Fan W; Zhou K; Zhao Y; Wu W; Chen H; Jin L; Chen G; Shi J; Wei Q; Zhang T; Du G; Mao Y; Lu D; Zhou L
    J Neurooncol; 2011 Nov; 105(2):211-8. PubMed ID: 21512825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
    Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
    BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.